Nesiritide (BNP) in the management of postoperative cardiac patients

Nader Moazami; Ralph J. Damiano; Marci S. Bailey; Rachel L. Hess; Jennifer S. Lawton; Marc R. Moon; Michael K. Pasque

doi:10.1016/S0003-4975(02)05009-9

Nesiritide (BNP) in the management of postoperative cardiac patients

Nader Moazami, Ralph J. Damiano, Marci S. Bailey, Rachel L. Hess, Jennifer S. Lawton, Marc R. Moon, Michael K. Pasque

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

Recombinant human B-type natriuretic peptide (BNP) is a promising new agent in the management of heart failure. The pharmacologic properties of BNP make it desirable to use in a subset of patients after cardiac surgical operations. Among these therapeutic potentials is the effect on markedly reducing pulmonary vascular resistance and central venous pressure with mild systemic vasodilatation. In addition, BNP directly effects the kidneys to promote natriuresis. We believe this agent to be useful in the treatment of the postcardiac surgery patients with left ventricular dysfunction and mild to moderate renal insufficiency. This report summarizes our experience in 2 patients.

Original language	English (US)
Pages (from-to)	1974-1976
Number of pages	3
Journal	Annals of Thoracic Surgery
Volume	75
Issue number	6
DOIs	https://doi.org/10.1016/S0003-4975(02)05009-9
State	Published - Jun 1 2003
Externally published	Yes

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0003-4975(02)05009-9

Cite this

@article{427fbabf7b4942e7a42045ff78f65050,

title = "Nesiritide (BNP) in the management of postoperative cardiac patients",

abstract = "Recombinant human B-type natriuretic peptide (BNP) is a promising new agent in the management of heart failure. The pharmacologic properties of BNP make it desirable to use in a subset of patients after cardiac surgical operations. Among these therapeutic potentials is the effect on markedly reducing pulmonary vascular resistance and central venous pressure with mild systemic vasodilatation. In addition, BNP directly effects the kidneys to promote natriuresis. We believe this agent to be useful in the treatment of the postcardiac surgery patients with left ventricular dysfunction and mild to moderate renal insufficiency. This report summarizes our experience in 2 patients.",

author = "Nader Moazami and Damiano, {Ralph J.} and Bailey, {Marci S.} and Hess, {Rachel L.} and Lawton, {Jennifer S.} and Moon, {Marc R.} and Pasque, {Michael K.}",

year = "2003",

month = jun,

day = "1",

doi = "10.1016/S0003-4975(02)05009-9",

language = "English (US)",

volume = "75",

pages = "1974--1976",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "6",

}

TY - JOUR

T1 - Nesiritide (BNP) in the management of postoperative cardiac patients

AU - Moazami, Nader

AU - Damiano, Ralph J.

AU - Bailey, Marci S.

AU - Hess, Rachel L.

AU - Lawton, Jennifer S.

AU - Moon, Marc R.

AU - Pasque, Michael K.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Recombinant human B-type natriuretic peptide (BNP) is a promising new agent in the management of heart failure. The pharmacologic properties of BNP make it desirable to use in a subset of patients after cardiac surgical operations. Among these therapeutic potentials is the effect on markedly reducing pulmonary vascular resistance and central venous pressure with mild systemic vasodilatation. In addition, BNP directly effects the kidneys to promote natriuresis. We believe this agent to be useful in the treatment of the postcardiac surgery patients with left ventricular dysfunction and mild to moderate renal insufficiency. This report summarizes our experience in 2 patients.

AB - Recombinant human B-type natriuretic peptide (BNP) is a promising new agent in the management of heart failure. The pharmacologic properties of BNP make it desirable to use in a subset of patients after cardiac surgical operations. Among these therapeutic potentials is the effect on markedly reducing pulmonary vascular resistance and central venous pressure with mild systemic vasodilatation. In addition, BNP directly effects the kidneys to promote natriuresis. We believe this agent to be useful in the treatment of the postcardiac surgery patients with left ventricular dysfunction and mild to moderate renal insufficiency. This report summarizes our experience in 2 patients.

UR - http://www.scopus.com/inward/record.url?scp=0037974601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037974601&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(02)05009-9

DO - 10.1016/S0003-4975(02)05009-9

M3 - Article

C2 - 12822655

AN - SCOPUS:0037974601

SN - 0003-4975

VL - 75

SP - 1974

EP - 1976

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 6

ER -

Nesiritide (BNP) in the management of postoperative cardiac patients

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this